Holen Sie sich die Stockscreener-App
1.33
1.48%
-0.02
Handel nachbörslich:
1.32
-0.01
-0.75%
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Aug Weekly: What is the long term forecast for Marker Therapeutics Inc stockPrice Action & AI Driven Stock Reports - baoquankhu1.vn
Marker Therapeutics (NASDAQ: MRKR) seeks approval to raise authorized shares to 130M - Stock Titan
MRKR SEC FilingsMarker Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
Will Marker Therapeutics Inc. stock outperform value stocks2025 Big Picture & Weekly Momentum Stock Picks - Naître et grandir
Market Pulse: Does Marker Therapeutics Inc have pricing powerJuly 2025 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
What is the long term forecast for Marker Therapeutics Inc stockPortfolio Risk Report & Safe Swing Trade Setups - baoquankhu1.vn
MRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MRKR: First-in-class MAR-T cell therapy shows high efficacy and safety in refractory lymphoma - TradingView
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times
How buybacks impact Marker Therapeutics Inc. stock value2025 Top Decliners & AI Based Buy/Sell Signal Reports - mfd.ru
Is Marker Therapeutics Inc. stock a safe buy before earningsMarket Weekly Review & Fast Moving Stock Trade Plans - mfd.ru
Marker Therapeutics sets date for 2026 annual shareholder meeting and proposal deadline - Investing.com Nigeria
Marker Therapeutics Sets Date for 2026 Annual Meeting - TipRanks
Portfolio Update: Why is Mattel Inc stock going upJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Marker Therapeutics, Inc. (NASDAQ:MRKR) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Can BioSig Technologies Inc benefit from deglobalizationPortfolio Performance Report & Safe Entry Trade Reports - baoquankhu1.vn
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology - manilatimes.net
Good Morning America puts Baylor T-cell cancer trial in national spotlight - Stock Titan
Good Morning America Features Baylor College of Medicine - GlobeNewswire
Institution Moves: Should I trade or invest in One Liberty Properties IncJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
MRKR stock up nearly 114% in 3 months: Here's what you need to know - MSN
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know - Finviz
Risk Analysis: Can Marker Therapeutics Inc outperform in the next rallyJuly 2025 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-20 15:10:37 - baoquankhu1.vn
Whale Trades: Does REBN have consistent dividend growthTrade Risk Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Marker Therapeutics (NASDAQ:MRKR) Cut to “Hold” at Zacks Research - Defense World
Jobs Data: Can PGHL disrupt its industryLayoff News & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Bearish Setup: Is Marker Therapeutics Inc a strong candidate for buy and holdJuly 2025 Final Week & AI Enhanced Trading Signals - baoquankhu1.vn
Is Marker Therapeutics Inc. on track to beat earningsPortfolio Update Report & Weekly Watchlist of Top Performers - bollywoodhelpline.com
High Growth Tech Stocks To Watch In The US Market January 2026 - simplywall.st
Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation - simplywall.st
Insider Trends: Will Marker Therapeutics Inc. stock benefit from commodity pricesWeekly Investment Recap & Low Risk Profit Maximizing Plans - Улправда
How sustainable is Marker Therapeutics Inc. stock dividend payout2025 Year in Review & Safe Capital Growth Plans - Улправда
Short Interest Drops in Twinstar Industries Limited After RallyJuly 2025 Opening Moves & Low Volatility Stock Suggestions - Улправда
Will Marker Therapeutics Inc. stock benefit from green energy trendsSell Signal & Real-Time Chart Pattern Alerts - Улправда
How strong is Marker Therapeutics Inc. stock balance sheetWeekly Risk Report & Stepwise Entry and Exit Trade Signals - Улправда
Will NEXT plc (NXG) stock gain from green policiesJuly 2025 Earnings & Intraday High Probability Setup Alerts - Улправда
Can Marker Therapeutics Inc. stock sustain market leadership2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - Улправда
Why Marker Therapeutics Inc. (GX1) stock could rally stronglyDay Trade & Verified High Yield Trade Plans - Улправда
Will Marker Therapeutics Inc. stock benefit from commodity pricesTrade Volume Report & Free Community Consensus Stock Picks - Улправда
Why Marker Therapeutics Inc. stock remains on buy listsJuly 2025 Earnings & Fast Exit and Entry Trade Guides - Улправда
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Breakouts Watch: How strong is Marker Therapeutics Inc. stock balance sheetWeekly Loss Report & Fast Entry High Yield Stock Tips - Bộ Nội Vụ
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy? - sharewise.com
Marker Therapeutics, Inc. (MRKR) now trades above golden cross: Time to buy? - MSN
Marker Therapeutics announces publication on MAR-T cells in pancreatic cancer - MSN
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
Is Marker Therapeutics Inc GX1 a good long term investmentMarket Sentiment Shifts & Buy Sell Signal Notifications - earlytimes.in
สล็อต www.mio555.com - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Brookline Capital raises Marker Therapeutics stock price target to $5.60 By Investing.com - Investing.com Canada
Marker Therapeutics Reports Positive Phase 1/2 Clinical Study Results for Multi-Antigen Targeted T Cells in Pancreatic Cancer Patients - Quiver Quantitative
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - The Manila Times
Baylor College of Medicine Publishes Promising Safety and - GlobeNewswire
Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to Hold - Defense World
MRKR stock touches 52-week low at $1.8 amid market challenges - MSN
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):